The carbohydrase market size in Asia Pacific is expected to be worth USD 30.77 billion in 2024 and USD 46.31 billion by 2029, growing at a CAGR of 8.52% from 2024 to 2029.
The Asia-Pacific carbohydrase market is showcasing significant potential in the mentioned forecast period. The regional market continues to build up momentum with the significant growth in the pharma industry over the recent period. This has led the traffic to turn in the direction of the market. Carbohydrase is a type of enzyme with a large family of amylase, cellulase, etc. Carbohydrase is a crucial raw material in different applications in various industries like food, beverages, pharmaceuticals, animal feed, textiles, leather, and others. One of the key purposes of carbohydrates in these industries is to ensure lower greenhouse gas emissions and avoid wastage of raw materials.
The pharmaceutical industry has witnessed evident growth lately, which has been a key factor in the favour of the carbohydrase market. Other major factors driving the growth include emerging applications of carbohydrates, advancements in technology in enzyme engineering, and increasing demand in Asia-Pacific.
On the other hand, the market faces few restraints as well. These include temperature and pH in alpha-amylase activity and high production costs. These factors have been holding down the market from reaching its actual potential.
Companies that play a prominent role in the Asia-Pacific carbohydrase market include Dyadic International, Inc., Novozymes, Advanced Enzymes, Royal DSM, Amano Enzyme Inc., CHR. Hansen Holding A/S, Specialty Enzymes, Verenium, AB Enzymes Gmbh and E.I. Dupont De Nemours & Co.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region